SRPT in the 13F filings
Sarepta Therapeutics Inc · CUSIP 803607100
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 27
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 6 listed it in both
- Shares listed
- 19,400,869
- combined, among listed positions
- Reported value
- $421m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 18 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,807,423.
Managers listing SRPT in Q1 2026
27 of 27 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Investments LPexisting position · 4,593,195 shares now+2,151,740
- Marshall Wace LLPexisting position · 725,068 shares now+581,575
- Citadel Advisors LLCexisting position · 652,169 shares now+533,436
- Renaissance Technologies LLCexisting position · 1,665,078 shares now+505,500
- Susquehanna International Group LLPexisting position · 897,532 shares now+469,923
Reductions
- AQR Capital Management LLCexisting position · 6,433,112 shares now-1,363,423
- D. E. Shaw & Co.existing position · 474,986 shares now-1,065,404
- Voloridge Investment Management LLCexisting position · 432,535 shares now-445,858
- Bridgewater Associates LPexisting position · 134,277 shares now-146,291
- PDT Partners LLCexisting position · 25,470 shares now-80,016
New positions and exits
New (3)
Exited (3)
- Point72 Asset Management LPwas $4.5m
- Schonfeld Strategic Advisors LLCwas $530k
- Quantbot Technologies LPwas $12k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 4 | $52m | n.a. | n.a. |
| Q3 2013 | 3 | $62m | n.a. | n.a. |
| Q4 2013 | 1 | $4.7m | n.a. | n.a. |
| Q1 2014 | 1 | $601k | n.a. | n.a. |
| Q2 2014 | 3 | $68m | n.a. | n.a. |
| Q3 2014 | 2 | $12m | n.a. | n.a. |
| Q4 2014 | 1 | $22m | n.a. | n.a. |
| Q1 2015 | 1 | $23m | n.a. | n.a. |
| Q2 2015 | 2 | $31m | n.a. | n.a. |
| Q3 2015 | 5 | $74m | n.a. | n.a. |
| Q4 2015 | 2 | $129m | n.a. | n.a. |
| Q1 2016 | 1 | $58m | n.a. | n.a. |
| Q2 2016 | 3 | $62m | n.a. | n.a. |
| Q3 2016 | 10 | $425m | n.a. | n.a. |
| Q4 2016 | 5 | $48m | n.a. | n.a. |
| Q1 2017 | 6 | $58m | n.a. | n.a. |
| Q2 2017 | 4 | $123m | n.a. | n.a. |
| Q3 2017 | 6 | $239m | n.a. | n.a. |
| Q4 2017 | 8 | $150m | n.a. | n.a. |
| Q1 2018 | 8 | $1.1bn | n.a. | n.a. |
| Q2 2018 | 20 | $2.6bn | n.a. | n.a. |
| Q3 2018 | 10 | $2.6bn | n.a. | n.a. |
| Q4 2018 | 13 | $2.1bn | n.a. | n.a. |
| Q1 2019 | 11 | $2.4bn | n.a. | n.a. |
| Q2 2019 | 11 | $2.9bn | n.a. | n.a. |
| Q3 2019 | 8 | $1.2bn | n.a. | n.a. |
| Q4 2019 | 9 | $2.5bn | n.a. | n.a. |
| Q1 2020 | 11 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 16 | $3.6bn | n.a. | n.a. |
| Q3 2020 | 11 | $3.1bn | n.a. | n.a. |
| Q4 2020 | 13 | $4.0bn | n.a. | n.a. |
| Q1 2021 | 11 | $1.3bn | n.a. | n.a. |
| Q2 2021 | 9 | $1.0bn | n.a. | n.a. |
| Q3 2021 | 10 | $1.2bn | n.a. | n.a. |
| Q4 2021 | 13 | $1.2bn | n.a. | n.a. |
| Q1 2022 | 12 | $1.1bn | n.a. | n.a. |
| Q2 2022 | 13 | $946m | n.a. | n.a. |
| Q3 2022 | 21 | $1.8bn | n.a. | n.a. |
| Q4 2022 | 21 | $1.9bn | n.a. | n.a. |
| Q1 2023 | 20 | $2.3bn | n.a. | n.a. |
| Q2 2023 | 13 | $1.8bn | n.a. | n.a. |
| Q3 2023 | 19 | $2.1bn | n.a. | n.a. |
| Q4 2023 | 12 | $1.3bn | 6 | 10 |
| Q1 2024 | 15 | $2.0bn | 9 | 5 |
| Q2 2024 | 15 | $2.0bn | 8 | 9 |
| Q3 2024 | 12 | $1.4bn | 7 | 5 |
| Q4 2024 | 9 | $1.2bn | 4 | 5 |
| Q1 2025 | 11 | $665m | 9 | 3 |
| Q2 2025 | 5 | $175m | 5 | 1 |
| Q3 2025 | 6 | $164m | 2 | 3 |
| Q4 2025 | 7 | $298m | 16 | 15 |
| Q1 2026 | 5 | $281m | 18 | 11 |
| Q2 2026 | 5 | $132m | 14 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
SRPT and LLY →SRPT and JNJ →SRPT and VRTX →Choose a stock to compare with SRPT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own SRPT, latest filings →Back to the 13F Explorer →